Synlab AG
XETRA:SYAB
Synlab AG
Cash from Investing Activities
Synlab AG
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Synlab AG
XETRA:SYAB
|
Cash from Investing Activities
€144.2m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
Cash from Investing Activities
-€544.2m
|
CAGR 3-Years
26%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
5%
|
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
Cash from Investing Activities
-€3.2B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
1%
|
Vita 34 AG
XETRA:V3V
|
Cash from Investing Activities
-€4.3m
|
CAGR 3-Years
-75%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-18%
|
|
E
|
Euroeyes International Eye Clinic Ltd
HKEX:1846
|
Cash from Investing Activities
-HK$131.8m
|
CAGR 3-Years
-51%
|
CAGR 5-Years
-50%
|
CAGR 10-Years
N/A
|
See Also
What is Synlab AG's Cash from Investing Activities?
Cash from Investing Activities
144.2m
EUR
Based on the financial report for Dec 31, 2023, Synlab AG's Cash from Investing Activities amounts to 144.2m EUR.
What is Synlab AG's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
-30%
The average annual Cash from Investing Activities growth rates for Synlab AG have been -30% over the past three years .